Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,316,888
New position
Shares Held
22,766
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#413
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Composition Wealth, LLC holds $115,127,781 across 14 Drug Manufacturers - General names. AZN ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,607 | $29,106,739 | |
| 2 | LLY |
ELI LILLY & Co
|
22,959 | $27,537,715 | |
| 3 | ABBV |
AbbVie Inc.
|
67,878 | $17,080,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
99,815 | $12,826,227 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
111,561 | $6,428,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
45,430 | $5,739,626 | |
| 7 | PFE |
Pfizer Inc
|
233,380 | $5,619,790 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
22,766 | $4,316,888 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,316,888 | 22,766 | Shares | Sole | 2026-07-22 | |
| No filing history on record for this holder in this stock. | ||||||